SPRO

Conviction 0HealthcareScan · Fri, Aug 7, 2026

SPRO$1.27+0.00%

ResistanceSupportVol 14Insider sell

Vol MA14 2.07M

May 8May 27Jun 15Jul 2Jul 22Aug 7

Spero Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.sperotherapeutics.com ↗

Price1.27

Change+0.00%

Gap+0.00%

Rel volume0.13×

Avg volume2.4M

Avg $ vol3.34M

SMA 201.36

SMA 502.02

SMA 2002.33

Price vs 50-37.20%

Price vs 200-45.59%

MA stackbearish

50/200 cross—

Supertrenddown · 1.54

RSI (14)31

MACD hist0.04

MACD crossbull · 3d

Stoch %K / %D53 / 41

ADX (14)50

+DI / −DI10 / 32

RSI divergenceBullish

MACD divergenceBullish

ATR %+9.06%

ADR %9.09%

52w high2.98

52w low1.15

From 52w high-57.38%

Above 52w low+10.43%

New 52w highNo

SqueezeOff

Bollinger width75.24%

%B0.41

Donchian pos15.08%

Donchian high2.34

Donchian low1.08

AVWAP (52w high)1.93

vs AVWAP high-34.13%

AVWAP (52w low)1.18

vs AVWAP low+7.35%

OBV trendDown

Chaikin MF (20)-0.20

Today vs 20d0.13×

Avg vol (14d)2.07M

Avg vol (20d)2.4M

Avg $ vol (20d)3.34M

Market cap73.53M

RS 3m (vs SPY)-54.54%

RS 6m (vs SPY)-56.55%

RS line new highNo

Trend template0/8

Technical rank8.3

1 week+8.55%

1 month-40.09%

3 months-49.40%

6 months-44.78%

1 year-43.81%

YTD-45.96%

P/E8.58

P/B1.39

P/S5.84

P/FCF-5.75

EPS0.1500

Div yield—

ROE16.19%

ROA14.52%

Debt/Eq—

Current10.50

EV/EBITDA2.76

Gross margin—

Net margin68.11%

Rev growth3292.45%

EPS growth112.50%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value17.41M

Revenue0

Net income-7.2M

Gross profit—

Free cash flow-12.78M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out57.9M

Employees25

ListedThu, Nov 2, 2017

Free float39.79M

Float %70.6%

Short interest2.11M

Days to cover1.3d

Short volume24.0%

Squeeze score17 / 100

Next earningsWed, Aug 12, 2026 · after (5d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank8.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.70

Support1.10

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SPRO

All disclosures →

No recent disclosed trades by Congress in SPRO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPRO · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Jackson Scott Thomas Director · Common Stock · 2026-06-23	Grant	10K	—	2026-06-23	2026-06-25
VINK PATRICK V.J.J. Director · Common Stock · 2026-06-23	Grant	10K	—	2026-06-23	2026-06-25
Tregoning Kathleen Director · Common Stock · 2026-06-23	Grant	10K	—	2026-06-23	2026-06-25
Deshpande Milind Director · Common Stock · 2026-06-23	Grant	10K	—	2026-06-23	2026-06-25
Deshpande Milind Director · Stock Option (right to buy) · 2026-06-23	Grant	20K	—	2026-06-23	2026-06-25
Jackson Scott Thomas Director · Stock Option (right to buy) · 2026-06-23	Grant	20K	—	2026-06-23	2026-06-25
THOMAS FRANK E Director · Stock Option (right to buy) · 2026-06-23	Grant	20K	—	2026-06-23	2026-06-25
VINK PATRICK V.J.J. Director · Stock Option (right to buy) · 2026-06-23	Grant	20K	—	2026-06-23	2026-06-25
Tregoning Kathleen Director · Stock Option (right to buy) · 2026-06-23	Grant	20K	—	2026-06-23	2026-06-25
Smith Cynthia Director · Common Stock · 2026-06-23	Grant	10K	—	2026-06-23	2026-06-25

SEC filings

EDGAR filings in SPRO · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.